Personalized Medicine – News and Features

Explore plasma proteomics innovations tackling the dynamic range challenge, revealing biomarkers and advancing personalized medicine with Professor Joshua Coon.

Women of African or South Asian genetic ancestry tend to develop breast cancer and die at a younger age than women of European ancestry, according to new research by Queen Mary University of London.

A recent Emory University study discovered a biological link between inflammation and motivational deficits in schizophrenia. Elevated C-reactive protein levels were associated with changes in brain circuits related to reward and motivation.

Scientists have identified mutated immune cell clones that drive intestinal inflammation in people with celiac disease, explaining why a gluten-free diet sometimes fails.

Researchers have created a groundbreaking 3D-printed artificial tumor tissue capable of replicating the in vivo conditions of patient-derived cancer cells, which can be used to predict prognosis.

A first-of-its-kind GWAS study has identified two genetic variants linked to breast cancer in black South African women.

Researchers have now substantiated that certain skin bacteria can protect us from the sun’s ultraviolet radiation, specifically by metabolizing cis-urocanic acid using an enzyme called urocanase.

The results of an international study shed new light on the underlying biological mechanisms that cause differences in health risks, symptoms and outcomes between males and females.

New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body’s immune response in advanced ovarian cancer.

Discover how next-generation sequencing is transforming diagnostics, guiding treatment decisions and shaping the future of personalized medicine.